The refinement of the critical region for the 2q31.2q32.3 deletion syndrome indicates candidate genes for mental retardation and speech impairment
- PMID: 20552675
- DOI: 10.1002/ajmg.b.31107
The refinement of the critical region for the 2q31.2q32.3 deletion syndrome indicates candidate genes for mental retardation and speech impairment
Abstract
Current literature provides more than 30 patients with interstitial deletions in chromosome 2q31q33. Only a few of them were studied using high-resolution methods. Among these, two patients had presented with a particular consistence of some clinical features associated to a deletion between bands q31.2 and q32.3 of chromosome 2. This clinical pattern, labeled as "2q31.2q32.3 syndrome," consists of multiple dysmorphisms, developmental delay, mental retardation and behavioural disturbances. We report an adult female patient with a 4.4 Mb deletion in the 2q31.2q32.3 region, showing facial dysmorphisms, mental retardation and absence of speech. The region overlaps with the deletion found in the two cases previously reported. The critical region points to a few genes, namely NEUROD1, ZNF804A, PDE1A, and ITGA4, which are good candidates to explain the cognitive and behavioural phenotype, as well as the severe speech impairment associated with the 2q31.2q32.3 deletion.
Similar articles
-
Critical region in 2q31.2q32.3 deletion syndrome: Report of two phenotypically distinct patients, one with an additional deletion in Alagille syndrome region.Mol Cytogenet. 2012 May 2;5(1):25. doi: 10.1186/1755-8166-5-25. Mol Cytogenet. 2012. PMID: 22550961 Free PMC article.
-
Molecular genetic characterization of a prenatally detected de novo interstitial deletion of chromosome 2q (2q31.1-q32.1) encompassing HOXD13, ZNF385B and ZNF804A associated with syndactyly and increased first-trimester nuchal translucency.Taiwan J Obstet Gynecol. 2017 Jun;56(3):398-401. doi: 10.1016/j.tjog.2017.04.026. Taiwan J Obstet Gynecol. 2017. PMID: 28600059
-
Clinical and molecular characterization of a patient with a 2q31.2-32.3 deletion identified by array-CGH.Am J Med Genet A. 2007 Apr 15;143A(8):858-65. doi: 10.1002/ajmg.a.31602. Am J Med Genet A. 2007. PMID: 17352388
-
2q31 microdeletion syndrome with the velocardiofacial phenotype and review of the literature: a case report.BMC Pediatr. 2024 Oct 9;24(1):641. doi: 10.1186/s12887-024-04843-7. BMC Pediatr. 2024. PMID: 39385145 Free PMC article. Review.
-
2q24-q31 deletion: report of a case and review of the literature.Eur J Med Genet. 2007 Jan-Feb;50(1):21-32. doi: 10.1016/j.ejmg.2006.09.001. Epub 2006 Sep 17. Eur J Med Genet. 2007. PMID: 17088112 Review.
Cited by
-
Delineation of 2q32q35 deletion phenotypes: two apparent "proximal" and "distal" syndromes.Case Rep Genet. 2013;2013:823451. doi: 10.1155/2013/823451. Epub 2013 Jun 9. Case Rep Genet. 2013. PMID: 23840981 Free PMC article.
-
Further delineation of the SATB2 phenotype.Eur J Hum Genet. 2014 Aug;22(8):1034-9. doi: 10.1038/ejhg.2013.280. Epub 2013 Dec 4. Eur J Hum Genet. 2014. PMID: 24301056 Free PMC article.
-
Critical region in 2q31.2q32.3 deletion syndrome: Report of two phenotypically distinct patients, one with an additional deletion in Alagille syndrome region.Mol Cytogenet. 2012 May 2;5(1):25. doi: 10.1186/1755-8166-5-25. Mol Cytogenet. 2012. PMID: 22550961 Free PMC article.
-
Sequencing of a patient with balanced chromosome abnormalities and neurodevelopmental disease identifies disruption of multiple high risk loci by structural variation.PLoS One. 2014 Mar 13;9(3):e90894. doi: 10.1371/journal.pone.0090894. eCollection 2014. PLoS One. 2014. PMID: 24625750 Free PMC article.
-
Zinc in Cognitive Impairment and Aging.Biomolecules. 2022 Jul 18;12(7):1000. doi: 10.3390/biom12071000. Biomolecules. 2022. PMID: 35883555 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous